Jämför metoder
Granska de valda metoderna sida vid sida; rader som skiljer sig är markerade.
| Adaptiv klinisk prövningsdesign× | Ekvivalens- / Icke-underlägsenhetsstudie× | |
|---|---|---|
| Ämnesområde | Försöksplanering | Försöksplanering |
| Familj | Hypothesis test | Hypothesis test |
| Ursprungsår≠ | 1994 | 1987 |
| Upphovsperson≠ | Bauer & Köhne | Schuirmann, D.J. / EMA regulatory framework |
| Typ≠ | Adaptive hypothesis test with interim analyses | Parametric equivalence / non-inferiority test |
| Ursprungskälla≠ | Bauer, P. & Köhne, K. (1994). Evaluation of Experiments with Adaptive Interim Analyses. Biometrics, 50(4), 1029–1041. DOI ↗ | Schuirmann, D.J. (1987). A Comparison of the Two One-Sided Tests Procedure and the Power Approach. Journal of Pharmacokinetics and Biopharmaceutics, 15(6), 657–680. link ↗ |
| Alias≠ | adaptive design, group sequential design, sample size re-estimation, platform trial | non-inferiority trial, bioequivalence study, active-control trial, Denklik ve Üstünlük Olmayan Çalışma (Equivalence / Non-Inferiority) |
| Närliggande≠ | 3 | 6 |
| Sammanfattning≠ | Adaptive clinical trial design is a flexible experimental framework, formalised by Bauer and Köhne in 1994, in which pre-specified rules allow the trial to be modified mid-course — adjusting sample size, treatment arms, or randomisation ratios — based on accumulating interim data while rigorously controlling the Type I error rate. | An equivalence or non-inferiority trial is a clinical study design that tests whether a new intervention is clinically equivalent to, or no worse than, an established standard by a pre-specified margin. Codified in Schuirmann's 1987 Two One-Sided Tests (TOST) framework and embedded in EMA and FDA regulatory guidance, this design is the regulatory standard for generic drug approval and medical device testing. |
| ScholarGateDatamängd ↗ |
|
|